Clinical Trial Update: Effect of Rozerem on the Perception of GERD Symptoms in Patients With Chronic Insomnia. [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating whether Rozerem (ramelteon) influences the perception of gastroesophageal reflux symptoms in patients with chronic insomnia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Insomnia

Drugs mentioned

• ROZEREM (ramelteon)

Snippet

Sponsor: Southern Arizona VA Health Care System | Conditions: Gastroesophageal Reflux Disease, Chronic Insomnia | Phase 3 | Status: UNKNOWN